BridgeMD
New treatment option for Cognitive Assessment
Official title Evaluation of the Impact of a Nutritional Formulation on Cognitive Performance Following Stress Exposure.
ClinicalTrials.gov ID: NCT07319117
What this study is testing
- What it's testing
- The proposed project will evaluate the synergistic effects of a nutritional formulation, 'Think Tank' on cognitive performance following exposure to a psychological and physical stressor. Adopting a double-blind repeated measures cross-over design, middle-aged females (40-60 years) will be recruited to take part in a two-stage research study that will examine whether the formulation enhances cognitive performance and subjective well-being following the challenge of a stressor, compared to placebo.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 60, women only. Healthy volunteers may be eligible.
You may be able to join if
- Willing and able to provide written informed consent (in English)
- Aged 40-60
- Female
- Daily caffeine drinkers
- Healthy and free from significant physical and psychiatric disorders
You likely can't join if
- Current cigarette smokers/vapers.
- Known food allergy or intolerance to the investigational products or control products.
- Not willing to consume coffee.
- Individuals diagnosed with psychiatric/mental health conditions.
- Individuals engaging in recreational drug use.
- Individuals with diagnosed cardiovascular conditions (e.g. heart disease, high blood pressure)
See the full eligibility criteria
- Willing and able to provide written informed consent (in English)
- Aged 40-60
- Female
- Daily caffeine drinkers
- Healthy and free from significant physical and psychiatric disorders
- Current cigarette smokers/vapers.
- Known food allergy or intolerance to the investigational products or control products.
- Not willing to consume coffee.
- Individuals diagnosed with psychiatric/mental health conditions.
- Individuals engaging in recreational drug use.
- Individuals with diagnosed cardiovascular conditions (e.g. heart disease, high blood pressure)
- Individuals taking prescribed medication except contraceptives/hormone replacement therapy
- Individuals suffering from Raynaud's or circulatory issues
- Individuals who have suffered an injury or infection in their hand/arm in the last month
- Individuals who have suffered from chronic pain conditions or experience extreme numbness or pain in response to cold temperatures.
- Previous brain injury/brain surgery
- Individuals who work night shifts.
- Currently pregnant or breastfeeding.
- Previous participants in a laboratory stress protocol.
The study team makes the final eligibility decision.
Where it's taking place
- Leeds, West Yorkshire, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 40 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Leeds, West Yorkshire, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.